At a glance
ClinicalIndex Comparison RecordN/ACompleted· 21 enrolled
Drug / intervention
BrachyGel VHPSdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Non-Inferiority Study of a Hydrogel Packing System Compared to Standard of Care Packing During Image-Guided High-Dose Rate Brachytherapy Boost for Cervical Cancer
In Brief
A clinical study evaluating BrachyGel VHPS for Cervical Cancer. Completed, enrolled 21 participants across 1 site.
Detailed Summary
In this study, a new, low cost packing system ("BrachyGel VHPS") is being tested as a packing option during brachytherapy along with standard options to make sure that it keeps the unrelated organs away from radiation at least as well as the standard options, and to better understand the safety and patient discomfort associated with BrachyGel VHPS and the standard packing options.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCervical Cancer
CountriesUnited States
CollaboratorsBrachyFoam, LLC
Timeline
N/ACompletedFinished
202120222023202420252026
First PostedAug 2020
Enrollment StartMar 2021
Primary CompletionDec 2022
Study CompletionOct 2024
TodayJul 2026
First PostedAug 5, 2020
Enrollment StartMar 17, 2021
Primary CompletionDec 9, 2022
Study CompletionOct 31, 2024
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 5.9 years ago
Interventions
BrachyGel VHPSdevice
Packing system for administering brachytherapy in cervical cancer patients